• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉量和肌肉质量均是预测终末期肝病患者等待移植期间死亡率的指标。

Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease.

机构信息

Department of Dietetics, Leiden University Medical Center, Leiden, the Netherlands.

Department of Dietetics, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Clin Nutr ESPEN. 2021 Apr;42:272-279. doi: 10.1016/j.clnesp.2021.01.022. Epub 2021 Feb 10.

DOI:10.1016/j.clnesp.2021.01.022
PMID:33745592
Abstract

BACKGROUND AND AIMS

Malnutrition is highly prevalent in patients with end-stage liver disease (ESLD) and associated with impaired clinical outcome. Previous studies focused on one component of body composition and not in combination with nutritional intake, while both are components of the nutritional status. We aimed to evaluate the most important risk factors regarding body composition (muscle mass, muscle quality and fat mass) and nutritional intake (energy and protein intake) for waiting list mortality in patients with ESLD awaiting liver transplantation (LTx).

METHODS

Consecutive patients with ESLD listed for LTx between 2007 and 2014 were investigated. Muscle mass quantity (Skeletal Muscle Mass Index, SMI), and muscle quality (Muscle Attenuation, MA), and various body fat compartments were measured on computed tomography using SliceOmatic. Nutritional intake (e.g. energy and protein intake) was assessed. Multivariable stepwise forward Cox regression analysis was used for statistical analysis.

RESULTS

261 Patients (mean age 54 years, 74.7% male) were included. Low SMI and MA were found to be statistically significant predictors of an increased risk for waiting list mortality in patients with ESLD, with a HR of 2.580 (95%CI 1.055-6.308) and HR of 9.124 (95%CI 2.871-28.970), respectively. No association between percentage adipose tissue, and protein and energy intake with waiting list mortality was found in this study.

CONCLUSION

Both low muscle quantity and quality, and not nutritional intake, were independent risk factors for mortality in patients with ESLD.

摘要

背景与目的

终末期肝病(ESLD)患者营养不良的发生率很高,与临床预后不良有关。以前的研究集中在身体成分的一个组成部分上,而不是与营养摄入相结合,而这两者都是营养状况的组成部分。我们旨在评估与等待肝移植(LTx)的 ESLD 患者等待名单死亡率相关的最重要的身体成分(肌肉量、肌肉质量和脂肪量)和营养摄入(能量和蛋白质摄入)的风险因素。

方法

研究了 2007 年至 2014 年间接受 LTx 的 ESLD 连续患者。使用 SliceOmatic 在计算机断层扫描上测量肌肉质量量(骨骼肌指数,SMI)和肌肉质量(肌肉衰减,MA),以及各种体脂区室。评估营养摄入(例如能量和蛋白质摄入)。使用多变量逐步向前 Cox 回归分析进行统计分析。

结果

261 例患者(平均年龄 54 岁,74.7%为男性)入选。低 SMI 和 MA 被发现是 ESLD 患者等待名单死亡率增加的统计学显著预测因素,风险比分别为 2.580(95%CI 1.055-6.308)和 9.124(95%CI 2.871-28.970)。在这项研究中,没有发现体脂肪百分比、蛋白质和能量摄入与等待名单死亡率之间存在关联。

结论

低肌肉量和质量,而不是营养摄入,是 ESLD 患者死亡的独立危险因素。

相似文献

1
Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease.肌肉量和肌肉质量均是预测终末期肝病患者等待移植期间死亡率的指标。
Clin Nutr ESPEN. 2021 Apr;42:272-279. doi: 10.1016/j.clnesp.2021.01.022. Epub 2021 Feb 10.
2
Association between skeletal muscle index prior to liver transplantation and 1-year mortality posttransplant.肝移植前骨骼肌指数与移植后 1 年死亡率的关系。
JPEN J Parenter Enteral Nutr. 2023 Sep;47(7):867-877. doi: 10.1002/jpen.2508. Epub 2023 May 15.
3
A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.一个包含肌肉减少症的模型在预测肝硬化肝移植候选者等待名单死亡率方面优于 MELD 评分:一项全国队列的竞争风险分析。
J Hepatol. 2018 Apr;68(4):707-714. doi: 10.1016/j.jhep.2017.11.030. Epub 2017 Dec 6.
4
Computed Tomography Measures of Nutrition in Patients With End-Stage Liver Disease Provide a Novel Approach to Characterize Deficits.计算机断层扫描对终末期肝病患者营养状况的测量为表征营养缺乏提供了一种新方法。
Transplant Proc. 2018 Dec;50(10):3501-3507. doi: 10.1016/j.transproceed.2018.06.006. Epub 2018 Jun 27.
5
Insufficient Protein Intake Is Associated With Increased Mortality in 630 Patients With Cirrhosis Awaiting Liver Transplantation.蛋白质摄入不足与630例等待肝移植的肝硬化患者死亡率增加有关。
Nutr Clin Pract. 2015 Aug;30(4):530-6. doi: 10.1177/0884533614567716. Epub 2015 Feb 9.
6
Effect of a 12-week nutritional intervention in the food intake of patients on the waiting list for liver transplantation: A secondary analysis of a randomized controlled trial.营养干预对肝移植等待患者食物摄入量的影响:一项随机对照试验的二次分析。
Clin Nutr. 2024 Jun;43(6):1278-1290. doi: 10.1016/j.clnu.2024.03.023. Epub 2024 Apr 3.
7
Impaired lower limb muscle mass, quality and function in end stage liver disease: A cross-sectional study.终末期肝病患者下肢肌肉质量、力量和功能受损:一项横断面研究。
Exp Physiol. 2023 Aug;108(8):1066-1079. doi: 10.1113/EP091157. Epub 2023 May 11.
8
Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.终末期肝病患者的运动和体育锻炼:改善等待肝移植期间的功能状态和肌肉减少症。
Liver Transpl. 2018 Jan;24(1):122-139. doi: 10.1002/lt.24958.
9
Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.低皮下脂肪量与肝硬化女性患者的死亡率升高相关。
J Hepatol. 2018 Sep;69(3):608-616. doi: 10.1016/j.jhep.2018.04.015. Epub 2018 Apr 28.
10
Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.低骨骼肌量与肝硬化患者肝移植名单上的住院费用增加相关——一项回顾性研究。
Transpl Int. 2018 Feb;31(2):165-174. doi: 10.1111/tri.13048. Epub 2017 Sep 21.

引用本文的文献

1
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial.口服LPCN 1148改善男性肝硬化患者的肌肉减少症和肝性脑病:一项随机、安慰剂对照的2期试验。
Hepatology. 2025 Jun 1;81(6):1764-1775. doi: 10.1097/HEP.0000000000001146. Epub 2025 Jan 31.
2
Utilizing a novel MRI technique to identify adverse muscle composition in end-stage liver disease: A pilot study.利用一种新的 MRI 技术鉴定终末期肝病中的不良肌肉成分:一项初步研究。
Ann Hepatol. 2024 Jul-Aug;29(4):101508. doi: 10.1016/j.aohep.2024.101508. Epub 2024 May 6.
3
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis.
肌内脂肪变性在肝硬化患者中的流行情况及其对预后的影响:系统评价和荟萃分析。
Hepatol Int. 2024 Apr;18(2):688-699. doi: 10.1007/s12072-023-10632-8. Epub 2024 Feb 8.
4
The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis.肌少脂症的存在与年龄、肝病严重程度及不良预后相关,且可能代表肝硬化患者肌肉减少症的前驱阶段。
J Clin Med. 2023 May 7;12(9):3332. doi: 10.3390/jcm12093332.
5
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.非酒精性脂肪性肝病/代谢相关脂肪性肝病中的肌少症骨量减少症:慢性肝病中一个被低估的临床问题。
Int J Mol Sci. 2023 Apr 19;24(8):7517. doi: 10.3390/ijms24087517.
6
Improving the prognosis before and after liver transplantation: Is muscle a game changer?改善肝移植前后的预后:肌肉是改变游戏规则的因素吗?
World J Gastroenterol. 2022 Oct 28;28(40):5807-5817. doi: 10.3748/wjg.v28.i40.5807.
7
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.肝移植后发生的非酒精性脂肪性肝病或非酒精性脂肪性肝炎的代谢机制与治疗。
Nat Rev Endocrinol. 2022 Oct;18(10):638-650. doi: 10.1038/s41574-022-00711-5. Epub 2022 Jul 15.
8
Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.骨骼肌病理性脂肪浸润(肌脂肪病)与肝硬化患者的死亡率升高相关。
Cells. 2022 Apr 14;11(8):1345. doi: 10.3390/cells11081345.
9
Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.肝硬化性肌内脂肪变性:诊断、病理生理机制及潜在干预措施的综述。
Cells. 2022 Apr 4;11(7):1216. doi: 10.3390/cells11071216.
10
Should sarcopenia be an additional factor enough to affect liver transplant decision-making?肌肉减少症是否足以成为影响肝移植决策的另一个因素?
Hepatobiliary Surg Nutr. 2021 Dec;10(6):884-886. doi: 10.21037/hbsn-2021-19.